1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Radioisotopes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Market by Application
1.3.1 Global Medical Radioisotopes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Radioisotopes Market Perspective (2018-2029)
2.2 Medical Radioisotopes Growth Trends by Region
2.2.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical Radioisotopes Historic Market Size by Region (2018-2023)
2.2.3 Medical Radioisotopes Forecasted Market Size by Region (2024-2029)
2.3 Medical Radioisotopes Market Dynamics
2.3.1 Medical Radioisotopes Industry Trends
2.3.2 Medical Radioisotopes Market Drivers
2.3.3 Medical Radioisotopes Market Challenges
2.3.4 Medical Radioisotopes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Radioisotopes Players by Revenue
3.1.1 Global Top Medical Radioisotopes Players by Revenue (2018-2023)
3.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2018-2023)
3.2 Global Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Radioisotopes Revenue
3.4 Global Medical Radioisotopes Market Concentration Ratio
3.4.1 Global Medical Radioisotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Radioisotopes Revenue in 2022
3.5 Medical Radioisotopes Key Players Head office and Area Served
3.6 Key Players Medical Radioisotopes Product Solution and Service
3.7 Date of Enter into Medical Radioisotopes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Radioisotopes Breakdown Data by Type
4.1 Global Medical Radioisotopes Historic Market Size by Type (2018-2023)
4.2 Global Medical Radioisotopes Forecasted Market Size by Type (2024-2029)
5 Medical Radioisotopes Breakdown Data by Application
5.1 Global Medical Radioisotopes Historic Market Size by Application (2018-2023)
5.2 Global Medical Radioisotopes Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medical Radioisotopes Market Size (2018-2029)
6.2 North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical Radioisotopes Market Size by Country (2018-2023)
6.4 North America Medical Radioisotopes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Radioisotopes Market Size (2018-2029)
7.2 Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical Radioisotopes Market Size by Country (2018-2023)
7.4 Europe Medical Radioisotopes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Radioisotopes Market Size (2018-2029)
8.2 Asia-Pacific Medical Radioisotopes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical Radioisotopes Market Size by Region (2018-2023)
8.4 Asia-Pacific Medical Radioisotopes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Radioisotopes Market Size (2018-2029)
9.2 Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical Radioisotopes Market Size by Country (2018-2023)
9.4 Latin America Medical Radioisotopes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Radioisotopes Market Size (2018-2029)
10.2 Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023)
10.4 Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Detail
11.1.2 NRG Business Overview
11.1.3 NRG Medical Radioisotopes Introduction
11.1.4 NRG Revenue in Medical Radioisotopes Business (2018-2023)
11.1.5 NRG Recent Development
11.2 IRE
11.2.1 IRE Company Detail
11.2.2 IRE Business Overview
11.2.3 IRE Medical Radioisotopes Introduction
11.2.4 IRE Revenue in Medical Radioisotopes Business (2018-2023)
11.2.5 IRE Recent Development
11.3 ANSTO
11.3.1 ANSTO Company Detail
11.3.2 ANSTO Business Overview
11.3.3 ANSTO Medical Radioisotopes Introduction
11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2018-2023)
11.3.5 ANSTO Recent Development
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Detail
11.4.2 NTP Radioisotopes Business Overview
11.4.3 NTP Radioisotopes Medical Radioisotopes Introduction
11.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023)
11.4.5 NTP Radioisotopes Recent Development
11.5 China National Nuclear Corporation
11.5.1 China National Nuclear Corporation Company Detail
11.5.2 China National Nuclear Corporation Business Overview
11.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction
11.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2018-2023)
11.5.5 China National Nuclear Corporation Recent Development
11.6 Rosatom
11.6.1 Rosatom Company Detail
11.6.2 Rosatom Business Overview
11.6.3 Rosatom Medical Radioisotopes Introduction
11.6.4 Rosatom Revenue in Medical Radioisotopes Business (2018-2023)
11.6.5 Rosatom Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Medical Radioisotopes Introduction
11.7.4 Nordion Revenue in Medical Radioisotopes Business (2018-2023)
11.7.5 Nordion Recent Development
11.8 Eckert & Ziegler Strahlen
11.8.1 Eckert & Ziegler Strahlen Company Detail
11.8.2 Eckert & Ziegler Strahlen Business Overview
11.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
11.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2018-2023)
11.8.5 Eckert & Ziegler Strahlen Recent Development
11.9 Polatom
11.9.1 Polatom Company Detail
11.9.2 Polatom Business Overview
11.9.3 Polatom Medical Radioisotopes Introduction
11.9.4 Polatom Revenue in Medical Radioisotopes Business (2018-2023)
11.9.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
